VANESSA M STULTS

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant O FALLON, IL NPI 1689869588

General Payments — all program years on this page

$368.51

  • Category: General Payments
  • Program years: PY2024
  • Record count: 20
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $368.51 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $368.5120

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $130.767
Amgen Inc. $38.402
PFIZER INC. $36.332
Exact Sciences Corporation $31.282
ABBVIE INC. $26.761
Abbott Laboratories $22.331
DEXCOM, INC. $19.871
Novo Nordisk AS $17.571
Astellas Pharma US Inc $16.081
Kowa Pharmaceuticals America, Inc. $15.731
Acerta Pharma LLC $13.401

By program year

Program yearAmountRecords
2024 $368.5120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100374759 Novo Nordisk Inc $17.57 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104345636 AstraZeneca Pharmaceuticals LP $13.40 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108268574 ABBVIE INC. $26.76 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113474883 Kowa Pharmaceuticals America, Inc. $15.73 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114524255 Exact Sciences Corporation $14.38 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114524257 Exact Sciences Corporation $16.90 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117694604 Amgen Inc. $19.18 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117694606 Amgen Inc. $19.22 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125199439 Abbott Laboratories $22.33 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131408774 PFIZER INC. $13.78 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132015865 PFIZER INC. $22.55 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135970784 Lilly USA, LLC $22.55 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135976804 Lilly USA, LLC $21.24 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135976806 Lilly USA, LLC $18.60 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135983168 Lilly USA, LLC $19.12 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135983170 Lilly USA, LLC $14.06 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135983172 Lilly USA, LLC $16.39 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135992650 Lilly USA, LLC $18.80 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139513897 Astellas Pharma US Inc $16.08 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153391102 Dexcom, Inc. $19.87 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.